AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2005
Dec 24, 2005
30786_dirs_2005-12-23_273f25a4-a5ae-4839-9954-e039da398fb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO)
CIK: 0000012208
Period of Report: 2005-12-22
Reporting Person: WADLER SANFORD (Vice President, General)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-12-22 | Bio-Rad A Common Stock | G | 153 | — | Disposed | 11481 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $10.75 | 2010-09-19 | Bio-Rad A Common Stock (5000) | 5000 | Direct |
| Incentive Stock Option (right to buy) | $11.57 | 2008-02-11 | Bio-Rad A Common Stock (6000) | 6000 | Direct |
| Incentive Stock Option (right to buy) | $11.94 | 2010-02-02 | Bio-Rad A Common Stock (8000) | 8000 | Direct |
| Incentive Stock Option (right to buy) | $28.61 | 2012-02-06 | Bio-Rad A Common Stock (7924) | 7924 | Direct |
| Incentive Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (5042) | 5042 | Direct |
| Incentive Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (2399) | 2399 | Direct |
| Incentive Stock Option (right to buy) | $57.49 | 2015-02-09 | Bio-Rad A Common Stock (1000) | 1000 | Direct |
| Non-Qualified Stock Option (right to buy) | $35.5 | 2013-02-05 | Bio-Rad A Common Stock (1972) | 1972 | Direct |
| Non-Qualified Stock Option (right to buy) | $53.75 | 2014-02-04 | Bio-Rad A Common Stock (3601) | 3601 | Direct |
| Non-Qualified Stock Option (right to buy) | $57.49 | 2015-02-09 | Bio-Rad A Common Stock (4000) | 4000 | Direct |
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13